Programs in biological Retrovirology
Retroviruses are pleiotropically found in animals. Two human retroviruses are especially important pathogens. These are the HIV and the human T-cell leukemia virus, HTLV. HIV causes AIDS while HTLV-I is the etiological agent for adult T-cell leukemia. There is a large amount of basic research being conducted on HIV and HTLV-I spanning gene expression, virus structure-assembly, integration, replication, and pathogenesis. Retro virology intends to cover areas of human and animal retrovirus research.
- Diagnosis of HIV infection in adults and children
- Resistance and treatment failure
- HIV-TB co-infection
Related Conference of Programs in biological Retrovirology
May 21-22, 2025
6th Annual Meeting on Infectious Diseases, Microbiology & Beneficial Microbes
Paris, France
May 21-22, 2025
12th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Paris, France
June 16-17, 2025
5th International Conference on Microbiology and Infectious Diseases
Amsterdam, Netherlands
September 22-23, 2025
11th International Conference on Infectious and Rare Diseases
Vancouver, Canada
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
October 30-31, 2025
20th World Conference on Infectious Diseases, Prevention and Control
Paris, France
December 11-12, 2025
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Prague, Czech Republic
Programs in biological Retrovirology Conference Speakers
Recommended Sessions
- Advancements in treatment of AIDS and vaccines for immune system
- AIDS and behavioral studies
- Diagnostic Tools for Immunological and Virological Monitoring of HIV Infection
- Epidemiology of HIV infection
- Historical significance of immunological studies and treatment of AIDS
- HIV Prevention
- HIV/AIDS
- HIV/AIDS-Related Cancer
- HIV/Viral HepatitisÂ
- Immune Responses
- Immunology of HIV/AIDS, STDs & STIs
- Infectious pathogens
- Novel findings on virology & immunology
- Paediatric HIV Treatment Initiative
- Preventing Mother-to-Child Transmission of HIV
- Programs in biological Retrovirology
- Sexually transmitted diseases
- Super and Co-Infections
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Advancement in the Diagnosis of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Advancements in Vaccines and Therapeutics - Infectious Diseases 2025 (France)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antibiotics and Anti-viral - Euro Infectious Diseases 2025 (Netherlands)
- Antigen-Antibody Reactions - Infectious Diseases 2025 (France)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Bacterial Infections and Diseases - Infectious Diseases 2025 (France)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Biofertilizers - Infectious Diseases 2025 (France)
- Biomarkers for Rare Disease Diagnosis and Treatment - Rare Diseases Congress 2025 (Netherlands)
- Biomedical Research - Rare Diseases Congress 2025 (Netherlands)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Challenges of Living with a Rare Disease - Rare Diseases Congress 2025 (Netherlands)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Clinical and Case Reports - INFECTIOUS DISEASES-2025 (France)
- Clinical Case Reports and Case Studies - Rare Diseases Congress 2025 (Netherlands)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Clinical Research on Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2025 (France)
- COVID-19 - Infectious Diseases 2025 (France)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Dermatological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Different Types of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Drug Discovery for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Emerging Technologies in Rare Disease Research - Rare Diseases Congress 2025 (Netherlands)
- Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Functional Genomics and Gene Therapy for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Fungal Infections - Euro Infectious Diseases 2025 (Netherlands)
- Fungal Infections - Infectious Diseases 2025 (France)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Gene Expression - Infectious Diseases 2025 (France)
- Genetic Testing and Counselling of Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Health Economics and Market Access for Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Euro Infectious Diseases 2025 (Netherlands)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2025 (France)
- Infectious Disease - Euro Infectious Diseases 2025 (Netherlands)
- Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases and Cancer - Infectious Diseases 2025 (France)
- Infectious Diseases and Immune Deficiencies - Rare Diseases Congress 2025 (Netherlands)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2025 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2025 (France)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Introduction and Causes of New Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Mutations - Infectious Diseases 2025 (France)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Neurological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2025 (France)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- Ophthalmological Infections - Euro Infectious Diseases 2025 (Netherlands)
- Orphan Drugs Potentiality - Rare Diseases Congress 2025 (Netherlands)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Paediatric Infectious Diseases - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infections - Euro Infectious Diseases 2025 (Netherlands)
- Parasitic Infections - Infectious Diseases 2025 (France)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Preventive Measures - Euro Infectious Diseases 2025 (Netherlands)
- Prion Diseases - Infectious Diseases 2025 (France)
- Probiotics and Prebiotics - Infectious Diseases 2025 (France)
- Public Health - Euro Infectious Diseases 2025 (Netherlands)
- Public Health - STD-HIV AIDS-2025 (USA)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Rare Autoimmune Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Bone Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Cancer - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases and Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Rare Diseases of the Heart and Vessels - Rare Diseases Congress 2025 (Netherlands)
- Rare Neurological Disorders - Rare Diseases Congress 2025 (Netherlands)
- Rare Nutritional and Metabolic Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Paediatric Diseases - Rare Diseases Congress 2025 (Netherlands)
- Rare Skin Diseases - Rare Diseases Congress 2025 (Netherlands)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Regulatory Considerations for Developing Orphan Drugs - Rare Diseases Congress 2025 (Netherlands)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2025 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- Respiratory tract infections - Euro Infectious Diseases 2025 (Netherlands)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases (STDs) and Infections (STIs) - Infectious Diseases 2025 (France)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Treatment and Advanced Therapies for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Tropical diseases - Euro Infectious Diseases 2025 (Netherlands)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2025 (France)
- Urinary Tract Infection - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines - Euro Infectious Diseases 2025 (Netherlands)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2025 (France)
- Vaccines and Vaccination for Rare Diseases - Rare Diseases Congress 2025 (Netherlands)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Veterinary Diseases - INFECTIOUS DISEASES-2025 (France)
- Veterinary Infectious Diseases - Infectious Diseases 2025 (France)
- Viral Infections - Euro Infectious Diseases 2025 (Netherlands)
- Viral Infections and Diseases - Infectious Diseases 2025 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2025 (France)